Ron Zwanziger


Ron Zwanziger is an American businessman. He is best known for founding and leading the diagnostic test manufacturer Alere.

Early Life and Education

Zwanziger was born in Israel in 1954 and raised on the island of Cyprus, after his family moved there in 1956.
He earned an engineering degree from Imperial College London in 1975 and an MBA from Harvard Business School in 1981.

Career

Medisense (1981-1991)

Along with three HBS classmates, Zwanziger co-founded Medisense Inc., a maker of glucose meters used in diabetes home care, in 1981. He served as CEO until 1991.
Originally, the company pursued 13 disparate biotechnology ideas, hoping one or another would pay off. By 1984, 10 of the projects had been scrapped, 2 had been sold or spun off, and the company focused on the remaining one, which concerned electrochemical biosensors.
In 1987, Medisense introduced the ExacTech, which was the first electrochemical biosensor-based glucose meter for home use. This technology required less blood to obtain a reading, and by 2008 was used in a majority of the 6 billion home blood glucose tests being performed annually. In his textbook on electrochemistry, Alan Bond of Monash University suggests that the commercial success of electrochemical home glucose monitoring "predominantly can be attributed to the introduction of the ExacTech system."
Medisense was acquired by Abbott Laboratories in 1996 for $876 million.

Alere (1991-2014)

Zwanziger founded Alere Inc., a diagnostic test manufacturer, in 1991. He served as CEO until 2014.
Alere's diabetes unit was sold to Johnson and Johnson in 2001 for $1.3 billion. With the 2001 acquisition of the subsidiary Unipath from Unilever, Alere became the leading manufacturer of ovulation and pregnancy tests. Alere acquired San Diego-based Biosite Inc. in a $1.7 billion hostile takeover in 2007. By 2012, Alere was the largest manufacturer in the HIV testing space, according to the nonprofit Population Services International.
Abbott acquired Alere in 2017 for $5.3 billion.

LumiraDx (2014-present)

Along with longtime partners Drs. David Scott and Jerry McAleer, Zwanziger co-founded the diagnostic test manufacturer LumiraDx in 2014, and he currently serves as CEO.
Funding rounds for Lumiradx included $270 million in 2018 and $302 million in 2020. In 2020, the company was reported to be developing tests for COVID-19.